(Q30430605)

13 October 2017

A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency (English)

1 reference

multicenter clinical trial

13 October 2017

0 references

Crohn's disease

0 references

author name string

Ali Keshavarzian

1

1 reference

13 October 2017

Lloyd Mayer

2

1 reference

13 October 2017

Bruce Salzberg

3

1 reference

13 October 2017

Michael Garone

4

1 reference

13 October 2017

Warren Finkelstein

5

1 reference

13 October 2017

Joseph Cappa

6

1 reference

13 October 2017

Myron Brand

7

1 reference

13 October 2017

Jon Hain

8

1 reference

13 October 2017

David Zelinger

9

1 reference

13 October 2017

Ronald Hegedus

10

1 reference

13 October 2017

Robert H Diamond

11

1 reference

13 October 2017

Ulka Campbell

12

1 reference

13 October 2017

Christi Lane

13

1 reference

13 October 2017

Paul Stang

14

1 reference

13 October 2017

John Watson

15

1 reference

13 October 2017

Fabio Cominelli

16

1 reference

13 October 2017

1 May 2007

1 reference

Gastroenterology & hepatology

13 October 2017

1 reference

13 October 2017

3

1 reference

13 October 2017

5

1 reference

13 October 2017

381-390

1 reference

Impact of kidney bone disease and its management on survival of patients on dialysis

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

A systematic review of adherence with medications for diabetes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Infliximab maintenance therapy for fistulizing Crohn's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Clinical experience with infliximab for Crohn's disease: the first 100 patients in Edmonton, Alberta

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Why do patients with ulcerative colitis relapse?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Adherence rates with infliximab therapy in Crohn's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Time-dependent associations between iron and mortality in hemodialysis patients

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Drug-cholinesterase-inhibitors persistence patterns in treated patients with dementia of Alzheimer type: retrospective comparative analysis of donepezil, rivastigmine and galantamine

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Patient nonadherence to medication in inflammatory bowel disease

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3099319

Compliance to Therapy in Patients on a Maintenance Dose of Sulfasalazine

26 November 2018

1 reference

12 December 2020

The incidence and management of infusion reactions to infliximab: a large center experience

1 reference

12 December 2020

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

12 December 2020

Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens

1 reference

12 December 2020

Persistence with hypertension treatment among community-dwelling BC seniors

1 reference

12 December 2020

Clinical experience with infliximab therapy in 100 patients with Crohn's disease

1 reference

12 December 2020

Identifiers

1 reference

13 October 2017

PubMed publication ID

21960854

1 reference